Biomedical subjects
E Frei
Publications and source records attributed to E Frei.
Clinical trials with adriamycin.
Explore the source record for details and available documents.
Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma.
Explore the source record for details and available documents.
Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia.
Explore the source record for details and available documents.
Cytogenetic studies and their clinical correlates in adults with acute leukemia.
Explore the source record for details and available documents.
The chemotherapy of human and animal acute leukemia.
Explore the source record for details and available documents.
Distribution and mechanism of clearance of L-asparaginase (NSC-109229).
Explore the source record for details and available documents.
Dose-schedule studies with hydroxyurea (NSC-32065) in malignant melanoma.
Explore the source record for details and available documents.
Phase I and phototoxicity studies of pseudourea (NSC-56054).
Explore the source record for details and available documents.
Definition of cure for Hodgkin's disease.
Explore the source record for details and available documents.
Possible role of cell kinetics in prediction of the response to cancer therapy.
Explore the source record for details and available documents.
Advances in the chemotherapy of acute leukemia.
Explore the source record for details and available documents.
Cell proliferation in human melanoma.
The cytokinetics of subcutaneous metastases in five patients with melanoma was studied. Multiple simultaneous biopsies following pulse labeling with tritiated thymidine were performed in one patient. There was relatively uniform labeling and mitotic indices among these. Within the individual tumors, there was some variation in the labeling index with small clusters of tumor cells having significantly higher labeling indices than more sparsely infiltrating tumor cells. Repetitive biopsies following pulse labeling were performed in two patients. The per cent labeled mitosis curves were similar in the two patients. By computer analysis a median G(2) period of 5.3 hr and an S period of 21 hr were obtained. The generation time (T(e)) was highly variable with a median of 3 days. This T(e) was consistent with that calculated from grain count studies in these patients. Two patients received either intermittent or continuous tritiated thymidine over a 10-20 day period. Analysis of the labeling index curve by computer fitting indicated a growth fraction of 20-30%. The growth fraction calculated by other indirect methods was consistent with the computer analysis. The potential tumor doubling time as calculated from the T(e) and growth fraction was much shorter than the actual doubling time indicating that cell loss was approximately 70% of the rate of cell production.
L-asparagine requirement and the effect of L-asparaginase on the normal and leukemic human bone marrow.
Explore the source record for details and available documents.
Comparative effects of the antitumor agents 5-(Dimethyltriazeno)-imidazole-4-carboxamide and 1,3-bis(2-chloroethyl)-1-nitrosourea on cell cycle of L1210 leukemia cells in vivo.
Explore the source record for details and available documents.
The curative treatment of lymphoma.
Explore the source record for details and available documents.
Pharmacological studies of the antitumor agent 6-methylthiopurine ribonucleoside.
Explore the source record for details and available documents.
Reaction patterns of dark- and light-adapted Hydra to light stimuli.
Explore the source record for details and available documents.